Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Raso Barnett, Livia ^a,b   Banky, Balazs ^a   Barbai, Tamas ^a   Becsagh, Peter ^a   Timar, Jozsef ^a,c   Raso, Erzsebet ^a,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG TUMOR; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE; TUMOR EMBOLISM; TUMOR MICROENVIRONMENT;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 84872305643     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053883     Document Type: Article

References (37)

1. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, et al. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A., 89(24), 12160-4.
2. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell. 61(7), 1303-13.
3. Goodison S, Urquidi V, Tarin D (1999) D44 cell adhesion molecules. Mol Pathol. 52(4), 189-96.
4. Reeder JA, Gotley DC, Walsh MD, Fawcett J, Antalis TM, (1998) Expression of antisense CD44 variant 6 inhibits colorectal tumour metastasis and tumour growth in a wound environment. Cancer Res 58: 3719-26.
5. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, et al. (1996) Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol. 179(1): 66-73.
6. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 4(1), 33-45.
7. Marhaba R, Zoller M (2004) CD44 in cancer progression: adhesion, migration and growth regulation J Mol Histol. 35(3), 211-31.
8. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N (1995) Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol., 128(4), 673-85.
9. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, et al. (1995) CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol., 128(4), 687-98.
10. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H (2002) CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev., 16(23), 3074-86.
11. Cheng C, Yaffe MB, Sharp PA (2006) A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev. 20(13),1715-20.
12. Naor D, Sionov RV, Ish-Shalom D (1997) CD44: structure, function, and association with the malignant process. Ad.v Cancer Res., 71, 241-319.
13. van Weering DH, Baas PD, Bos JL (1993) A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl. 3(2),100-6.
14. Haruyama K, Matsumura Y, Moriya Y, Kakizoe T, Ochiai A, et al. (1999) Clinicopathological significance of the expression of CD44v2 in colorectal cancer. Anticancer Res., 19(5C), 4421-8.
15. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM (1998) Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol., 33(3), 301-9.
16. Rodriguez C, Monges G, Rouanet P, Dutrillaux B, Lefrancois D, et al. (1995) CD44 expression patterns in breast and colon tumours: a PCR-based study of splice variants. Int J Cancer., 64(5), 347-54.
17. Seiter S, Tilgen W, Herrmann K, Schadendorf D, Patzelt E, et al. (1996) Expression of CD44 splice variants in human skin and epidermal tumours Virchows Arch. 428(3),141-9.
18. Wong LS, Cantrill JE, Morris AG, Fraser IA (1997) Expression of CD44 splice variants in colorectal cancer. Br J Surg., 84(3), 363-7.
19. Zalewski B (2004) Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features. World J Gastroenterol., 10(4), 583-5.
20. Yamada Y, Itano N, Narimatsu H, Kudo T, Hirohashi S, et al. (2003) CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction. Oncol. Rep. 10, 1919-1924.
21. Dome B, Somlai B, Ladanyi A, Fazekas K, Zoller M, et al. (2001) Expression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma. Virchows Arch. 439(5),628-35.
22. Pacifico MD, Grover R, Richman PI, Daley FM, Buffa F, et al. (2006) CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: Assessment by the use of tissue microarray. Int J Cancer. 118(6), 1460-4.
23. Yoshinari C, Mizusawa N, Byers HR, Akasaka T (1999) CD44 variant isoform CD44v10 expression of human melanoma cell lines is upregulated by hyaluronate and correlates with migration. Melanoma Res. 9(3), 223-31.
24. Recio JA, Merlino G (2003) Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Cancer Res. 63(7), 1576-82.
25. Manten-Horst E, Danen EH, Smit L, Snoek M, Le Poole IC, et al. (1995) Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumour progression and metastatic potential. Int J Cancer. 64(3), 182-8.
26. Ranuncolo SM, Ladeda V, Gorostidy S, Morandi A, Varela M, et al. (2002) Expression of CD44s and CD44 splice variants in human melanoma. Oncol Rep. 9(1), 51-6.
27. Suzuki H, Yamashiro K (2002) Reduced expression of CD44 v3 and v6 is related to invasion in lung adenocarcinoma. Lung Cancer., 38(2), 137-41.
28. Poncelet C, Walker F, Madelenat P, Bringuier AF, Scoazec JY, et al. (2001) Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumours: a possible diagnostic tool for the diagnosis of leiomyosarcoma. Hum Pathol., 32(11), 1190-6.
29. Desai B, Ma T, Zhu J, Chellaiah MA (2009) Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface J Cell Biochem.108(1),272-84.
30. Kopp R, Fichter M, Schalhorn G, Danescu J, Classen S (2009) Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas. Int J Mol Med. 24(5), 677-83.
31. Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG, (1990) Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitialcollagenase in human tumorigenic cell lines. Cancer Res. 50(19): 6184-91.
32. Tímár J, Tóvári J, Rásó E, Mészáros L, Bereczky B, et al. (2005) Platelet-mimicry of cancer cells: epiphenomenon with clinical significance. Oncology. 69(3): 185-201. Epub 2005 Sep 1.
33. Tóvári J, Gilly R, Rásó E, Paku S, Bereczky B, et al. (2005) Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models. Cancer Res. 65(16): 7186-93.
34. Takács J, Kopper L, Lapis K, Hegedüs C, (1981) Ultrastructure of human colorectal tumour xenografts maintained serially in immunosuppressed mice. Acta Morphol Acad Sci Hung. 29(2-3): 141-59.
35. Wang SJ, Wreesmann VB, Bourguignon LY, (2007) Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck. 29(6): 550-8.
36. Yang K, Tang Y, Habermehl GK, Iczkowski KA, (2010) Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity. BMC Cancer. 10(1): 16.
37. Bánky B, Rásó-Barnett L, Barbai T, Tímár J, Becságh P, et al. (2012) Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression. Molecular Cancer 11: 83.